Literature DB >> 6546399

Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase.

K E Anderson, C S Simionatto, G S Drummond, A Kappas.   

Abstract

Tin(Sn)-protoporphyrin is a potent competitive inhibitor of heme oxygenase and can also suppress naturally occurring or experimentally induced hyperbilirubinemia in animals. In this study we examined the plasma clearance of Sn-protoporphyrin, its persistence in tissues and the time course of heme oxygenase inhibition up to 7 days after administration of doses up to 50 mumol/kg b.w. to adult male rats. After s.c. doses the metalloporphyrin was rapidly and almost completely absorbed. Initial plasma clearance was log-linear with a T 1/2 of approximately 3 h after either i.v. or s.c. administration. Levels of Sn-protoporphyrin in most tissues rose during the first 2 h and persisted for up to 7 days. Concentrations were highest in kidney and liver, were considerably lower in spleen, lung, intestine, adrenal and testes, and as Sn-protoporphyrin concentrations in plasma declined, concentrations in these tissues eventually exceeded simultaneous plasma concentrations. This suggests a varying degree of uptake and binding of the metalloporphyrin in these tissues. There was little or no uptake of Sn-protoporphyrin in heart, brain and red cells. Markedly decreased heme oxygenase activity in liver, kidney and spleen persisted as did Sn-protoporphyrin up to 7 days. The total amount of Sn-protoporphyrin present in tissues and excreta was a fairly constant fraction of the dose (approximately 50%) at time intervals up to 7 days after injection. These results indicate that single doses of Sn-protoporphyrin are rapidly cleared from plasma and persist in tissues and potently inhibit heme oxygenase activity for prolonged periods.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546399

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  In vivo inhibition of renal heme oxygenase with an imidazole-dioxolane inhibitor.

Authors:  Eva Csongradi; Trinity Vera; John M Rimoldi; Rama S V Gadepalli; David E Stec
Journal:  Pharmacol Res       Date:  2010-03-23       Impact factor: 7.658

2.  Heat shock preconditioning reduces ischemic tissue necrosis by heat shock protein (HSP)-32-mediated improvement of the microcirculation rather than induction of ischemic tolerance.

Authors:  Yves Harder; Michaela Amon; Rene Schramm; Mirko Georgi; Andrej Banic; Dominique Erni; Michael D Menger
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

3.  Marked protection against acute renal and hepatic injury after nitrited myoglobin + tin protoporphyrin administration.

Authors:  Richard A Zager
Journal:  Transl Res       Date:  2015-06-10       Impact factor: 7.012

4.  Sn-protoporphyrin inhibition of fetal and neonatal brain heme oxygenase. Transplacental passage of the metalloporphyrin and prenatal suppression of hyperbilirubinemia in the newborn animal.

Authors:  G S Drummond; A Kappas
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

5.  The liver excretes large amounts of heme into bile when heme oxygenase is inhibited competitively by Sn-protoporphyrin.

Authors:  A Kappas; C S Simionatto; G S Drummond; S Sassa; K E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

6.  Sn-protoporphyrin rapidly and markedly enhances the heme saturation of hepatic tryptophan pyrrolase. Evidence that this synthetic metalloporphyrin increases the functional content of heme in the liver.

Authors:  A Kappas; G S Drummond; M K Sardana
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

7.  Prevention of neonatal hyperbilirubinaemia in non-human primates by Zn-protoporphyrin.

Authors:  M K Qato; M D Maines
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

8.  A Pharmacologic "Stress Test" for Assessing Select Antioxidant Defenses in Patients with CKD.

Authors:  Richard A Zager; Ali C M Johnson; Alvaro Guillem; Jeff Keyser; Bhupinder Singh
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-14       Impact factor: 8.237

9.  Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production.

Authors:  C S Simionatto; K E Anderson; G S Drummond; A Kappas
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

10.  An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin.

Authors:  G S Drummond; A Kappas
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.